Extendicare Inc. (TSE:EXE - Get Free Report) has earned a consensus recommendation of "Buy" from the eight ratings firms that are covering the stock, Marketbeat Ratings reports. Seven equities research analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is C$37.00.
A number of research analysts have recently commented on EXE shares. Royal Bank Of Canada upped their target price on Extendicare from C$38.00 to C$39.00 and gave the company an "outperform" rating in a research note on Friday, August 14th. National Bank Financial boosted their price objective on Extendicare from C$34.00 to C$40.00 and gave the company an "outperform" rating in a report on Wednesday, May 27th. TD upped their price objective on Extendicare from C$32.00 to C$39.00 and gave the company a "buy" rating in a research report on Monday, May 11th. BMO Capital Markets increased their target price on Extendicare from C$30.00 to C$38.00 in a research note on Wednesday, May 13th. Finally, Desjardins decreased their target price on Extendicare from C$40.00 to C$39.00 and set a "buy" rating for the company in a research report on Monday, August 10th.
Read Our Latest Analysis on EXE
Extendicare Price Performance
EXE stock opened at C$30.76 on Tuesday. The stock has a market cap of C$2.92 billion, a PE ratio of 23.55 and a beta of 1.59. Extendicare has a 12 month low of C$12.64 and a 12 month high of C$39.14. The company has a 50-day moving average price of C$35.08 and a 200 day moving average price of C$30.92. The company has a current ratio of 0.75, a quick ratio of 0.98 and a debt-to-equity ratio of 159.54.
Extendicare (TSE:EXE - Get Free Report) last posted its quarterly earnings data on Thursday, August 6th. The company reported C$0.32 earnings per share for the quarter. Extendicare had a net margin of 6.13% and a return on equity of 36.33%. The company had revenue of C$611.04 million for the quarter. Equities research analysts anticipate that Extendicare will post 0.6134729 earnings per share for the current year.
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which was paid on Monday, August 17th. Investors of record on Monday, August 17th were paid a $0.0441 dividend. This represents a c) annualized dividend and a yield of 1.7%. The ex-dividend date of this dividend was Friday, July 31st. Extendicare's dividend payout ratio (DPR) is currently 39.23%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
